Booster Shots

Oddities, musings and news from the health world

« Previous Post | Booster Shots Home | Next Post »

Obesity drugs lumber toward marketplace

October 28, 2009 |  3:16 pm

About this time last year, we were reporting on the failure of several investigational weight-loss medications. They included Sanofi-Aventis' rimonabant as well as two other drugs that aimed to work by blocking cannabinoid receptors in the brain.

However, one or more new weight-loss drugs may become available next year, based on research presented this week at the Obesity Society's annual meeting in Washington, D.C. Xenical was the last prescription weight-loss medication approved by the Food and Drug Administration, in 1999.

An update on the three leading candidates for approval:

  • Lorcaserin, made by Arena Pharmaceuticals, reported Phase 3 study results of 4,008 patients who took the medication for one year. Almost half of the patients lost 5% or more of their body weight, and 22.6% lost 10%.
  • Qnexa, made by Vivus Inc., is a combination of two drugs: phentermine and topiramate. In two Phase 3 studies of 3,750 patients, the average weight loss was 14.7% of body weight (37 pounds) after 56 weeks.
  • Contrave, made by Orexigen Therapeutics Inc., is also a combination of two medications: buproprion SR and naltrexone SR. In a Phase 3 study, one-third of patients lost 10% of body weight.
 

The manufacturers all reported acceptable safety profiles, but the FDA will be looking closely at that issue. Rimonabant reached late-stage clinical trials before being abandoned because patients reported an increase in depression symptoms and suicidal thoughts.

"Safety is of paramount importance in treating patients who are overweight or have obesity," Dr. Lee Kaplan, an associate professor of medicine at Harvard who presented the data on lorcaserin, said in a news release. "We need new therapies that help patients reduce their weight and improve cardiovascular factors such as high blood pressure and cholesterol, while avoiding cardiac toxicity and symptoms of depression."


-- Shari Roan

 

Post a comment
If you are under 13 years of age you may read this message board, but you may not participate.
Here are the full legal terms you agree to by using this comment form.

Comments are moderated, and will not appear until they've been approved.

If you have a TypeKey or TypePad account, please Sign In





Comments (1)

The problem with weight loss drugs is that they don't address the underlying issues that cause obesity. Sure, they may cause weight loss, but is that loss healthy, and when you stop taking the drugs will that weight loss be permanent. The most healthy way to lose weight and keep it off is to make changes in 4 main areas: nutrition, exercise, stress management, and sleep. By addressing these components we can improve quality of life and reach our weight loss goals. For more information, see my book, "How To Eat Fried Chicken and Be Thin Too" on Amazon or at strategicbookpublishing.com



Advertisement


The Latest | news as it happens

Recent Posts
test |  March 15, 2011, 4:00 pm »
Booster Shots has moved |  July 12, 2010, 6:02 pm »


Categories


Archives